According to the latest report by IMARC Group, titled “Cough Syrup Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global cough syrup market size reached US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7 Billion by 2027, exhibiting a growth rate (CAGR) of 4.4% during 2022-2027.
Cough Syrup Market Overview:
Cough syrup refers to a combination drug that is used to provide temporary relief from cough, common cold, hay fever, and other respiratory allergies. It is manufactured using non-opioid cough suppressants, expectorants, and antihistamine compounds to block the symptoms. The suppressants help in alleviating the symptoms of dry cough by minimizing the activity of the cough reflex and reducing the urge to cough. The expectorants aid in treating cough with mucus by loosening it, thereby making it easier to expel from the body. The antihistamines are utilized to relieve cough caused by minor throat or airway irritation. Cough syrups are generally prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in a wide variety of flavors, including cherry, orange, honey, and bubblegum.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The global sanitary napkin industry is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.
Get a Free Sample Copy of this Report: https://www.imarcgroup.com/cough-syrup-market/requestsample
Market Trends and Drivers:
The elevating prevalence of upper respiratory tract infection (URTI) and other respiratory disorders across countries is among the key factors stimulating the cough syrup market. Furthermore, the inflating health consciousness among the masses and convenient product availability in pharmacies and general stores are also propelling the global market. Moreover, various innovations, including the development of cough syrups with minimal side effects, are acting as other significant growth-inducing factors. Besides this, manufacturers are developing variants fortified with natural herbs and ingredients with immunity-boosting effects, which is further fueling the market growth. Apart from this, the growing expenditure capacities of the consumers and the expanding pharmaceutical industry are expected to positively influence the cough syrup market in the coming years.
Key Players Included in Global Research Report:
- Acella Pharmaceuticals LLC
- Bayer AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Reckitt Benckiser Group PLC
- Sun Pharmaceutical Industries Limited
- The Procter & Gamble Company
Cough Syrup Market Segmentation:
The report has segmented the global cough syrup market on the basis of product type, age group, distribution channel and region.
Breakup by Product Type:
- Cough Suppressants/Antitussives
- Combination Medications
Breakup by Age Group:
Breakup by Distribution Channel:
- Retail Pharmacy
- Hospital Pharmacy
- Online Pharmacy
Breakup by Region:
- North America
- Latin America
- Middle East and Africa
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800